Notably, Adora2b homodimers in GC strengthen downstream pro-tumor signaling (e.g., cAMP/PKA pathway activation), amplifying immunosuppression and metastasis compared to heterodimers. The gene discussed is ADORA2B; the disease is neoplasm.